Journal ArticleOPEN ACCESS

Quantification of tau phosphorylated at threonine 217 using a novel ultrasensitive immunoassay distinguishes Alzheimer’s disease from healthy controls

  • Kvartsberg H
  • Hanes J
  • Benedet A
  • et al.
Alzheimer's & Dementia (2020) 16(S5)
DOI: 10.1002/alz.043467
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: One of the major neuropathological hallmarks of a brain affected by

Cite

CITATION STYLE

APA

Kvartsberg, H., Hanes, J., Benedet, A. L., Ashton, N. J., Pascoal, T. A., Rosa‐Neto, P., … Blennow, K. (2020). Quantification of tau phosphorylated at threonine 217 using a novel ultrasensitive immunoassay distinguishes Alzheimer’s disease from healthy controls. Alzheimer’s & Dementia, 16(S5). https://doi.org/10.1002/alz.043467

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free